1. Home
  2. NHTC vs ALXO Comparison

NHTC vs ALXO Comparison

Compare NHTC & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Health Trends Corp.

NHTC

Natural Health Trends Corp.

HOLD

Current Price

$3.11

Market Cap

37.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$2.15

Market Cap

68.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHTC
ALXO
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.9M
68.3M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
NHTC
ALXO
Price
$3.11
$2.15
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.42
AVG Volume (30 Days)
30.7K
1.0M
Earning Date
05-06-2026
06-01-2026
Dividend Yield
12.50%
N/A
EPS Growth
N/A
31.02
EPS
N/A
N/A
Revenue
$39,776,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.41
52 Week High
$5.48
$2.66

Technical Indicators

Market Signals
Indicator
NHTC
ALXO
Relative Strength Index (RSI) 35.35 52.41
Support Level $2.95 $1.41
Resistance Level $3.35 $2.27
Average True Range (ATR) 0.16 0.27
MACD -0.05 -0.05
Stochastic Oscillator 1.35 23.08

Price Performance

Historical Comparison
NHTC
ALXO

About NHTC Natural Health Trends Corp.

Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: